Healthbeat - Your Source for Daily Health Trends and Medical News

What To Know About RFK Jr.’s Stances on Key Health Issues and What He Could Do at HHS

Robert F. Kennedy Jr.

FDA Approves First Menin Inhibitor for Acute Leukemia

(MedPage Today) -- The FDA granted full approval to the menin inhibitor revumenib (Revuforj) for adults and children 1 year and older with relapsed/refractory acute leukemia and a lysine methyltransf

Stalemate breaks on telehealth prescriptions of stimulants and addiction treatment

The DEA grants a one-year extension on telehealth prescription of addiction medications, kicking resolution on a fraught issue to the second Trump administration.

Clozapine's REMS Program on the Chopping Block at Upcoming FDA Meeting

(MedPage Today) -- Is a risk evaluation and mitigation strategy (REMS) still needed for clozapine? That's what a joint meeting of two FDA advisory committees will discuss on Tuesday.

Physician Groups Quiet on RFK Jr. Nomination for HHS Secretary

(MedPage Today) -- The response from physician groups to President-elect Donald Trump's nomination of Robert F. Kennedy Jr. for HHS secretary has been rather measured so far.

Higher BP Linked to Faster Visual Field Progression in Glaucoma

(MedPage Today) -- Higher mean blood pressure (BP) levels were associated with faster rates of visual field progression in patients with glaucoma, according to a retrospective cohort study.

STAT+: How RFK Jr. could strip legal protections from vaccine makers as HHS Secretary

A bureaucratic maneuver could help RFK Jr. upend decades of settled policy on vaccines.

Streeting warns Britons against having cheap cosmetic surgery abroad

Wes Streeting speaks out after deaths in Turkey among women travelling for procedures such as butt liftsBritons should resist the temptation to have cosmetic surgery abroad at “rock-bottom” prices

A Potential Reason Behind COVID Vaccines' Waning Benefit

(MedPage Today) -- The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning protection compared with vaccines for influenza or tetan

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

(MedPage Today) -- Patients with metastatic urothelial carcinoma who achieved a complete response after more than 8.

All News